{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:02:17Z","timestamp":1792425737901,"version":"4.5.0"},"reference-count":158,"publisher":"The Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"DOI":"10.1210\/jc.2017-01138","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T14:07:16Z","timestamp":1501682836000},"page":"3647-3661","source":"Crossref","is-referenced-by-count":118,"title":["Managing Menopausal Symptoms and Associated Clinical Issues in Breast Cancer Survivors"],"prefix":"10.1210","volume":"102","author":[{"given":"Richard J","family":"Santen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A","family":"Stuenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnn V","family":"Pinkerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Gompel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Lumsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,8,2]]},"reference":[{"issue":"1","key":"key\n\t\t\t\t20171006135948_B1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"key\n\t\t\t\t20171006135948_B2","first-page":"399.","article-title":"Cancer statistics","volume":"39","year":"1989","journal-title":"CA Cancer J Clin"},{"key":"key\n\t\t\t\t20171006135948_B3","first-page":"1","volume-title":"Cancer Treatment and Survivorship Facts and Figures 2014\u20132015","author":"American Cancer Society","year":"2017"},{"issue":"12","key":"key\n\t\t\t\t20171006135948_B4","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","year":"2010","journal-title":"Int J Cancer"},{"issue":"4","key":"key\n\t\t\t\t20171006135948_B5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.maturitas.2011.09.008","article-title":"Improving quality of life after breast cancer: dealing with symptoms","volume":"70","year":"2011","journal-title":"Maturitas"},{"issue":"10","key":"key\n\t\t\t\t20171006135948_B6","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/GME.0000000000000219","article-title":"Menopausal symptoms in breast cancer survivors nearly 6 years after diagnosis","volume":"21","year":"2014","journal-title":"Menopause"},{"issue":"5","key":"key\n\t\t\t\t20171006135948_B7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/jnci\/djr541","article-title":"Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review","volume":"104","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"key\n\t\t\t\t20171006135948_B8","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.steroids.2007.05.003","article-title":"Superiority of gas chromatography\/tandem mass spectrometry assay (GC\/MS\/MS) for estradiol for monitoring of aromatase inhibitor therapy","volume":"72","year":"2007","journal-title":"Steroids"},{"key":"key\n\t\t\t\t20171006135948_B9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.steroids.2014.08.007","article-title":"Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole","volume":"99","year":"2015","journal-title":"Steroids"},{"issue":"9","key":"key\n\t\t\t\t20171006135948_B10","first-page":"2658","article-title":"Use of ultrasensitive recombinant cell bioassay to measure estrogen levels in women with breast cancer receiving the aromatase inhibitor, letrozole","volume":"80","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20171006135948_B11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1210\/jc.2010-1679","article-title":"Clinical review: Effect of endocrine therapies on bone in breast cancer patients","volume":"96","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171006135948_B12","doi-asserted-by":"crossref","unstructured":"Santen RJ , AllredDC, ArdoinSP, ArcherDF, BoydN, BraunsteinGD, BurgerHG, ColditzGA, DavisSR, GambaccianiM, GowerBA, HendersonVW, JarjourWN, KarasRH, KleerekoperM, LoboRA, MansonJE, MarsdenJ, MartinKA, MartinL, PinkertonJV, RubinowDR, TeedeH, ThiboutotDM, UtianWH; Endocrine Society. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2010;95(7 Suppl 1):s1\u2013s66.","DOI":"10.1210\/jc.2009-2509"},{"issue":"11","key":"key\n\t\t\t\t20171006135948_B13","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1210\/jc.2015-2236","article-title":"Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline","volume":"100","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B14","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1530\/EJE-15-0814","article-title":"Endocrine dilemma: managing menopausal symptoms after breast cancer","volume":"174","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"key\n\t\t\t\t20171006135948_B15","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.mayocp.2016.04.009","article-title":"Management of hormone deprivation symptoms after cancer","volume":"91","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"key\n\t\t\t\t20171006135948_B16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.maturitas.2016.07.018","article-title":"Menopausal hormone therapy in cancer survivors: a narrative review of the literature","volume":"92","year":"2016","journal-title":"Maturitas"},{"issue":"2","key":"key\n\t\t\t\t20171006135948_B17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.maturitas.2011.03.010","article-title":"Overview of long term care of breast cancer survivors","volume":"69","year":"2011","journal-title":"Maturitas"},{"issue":"4","key":"key\n\t\t\t\t20171006135948_B18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/gme.0b013e3181d672f6","article-title":"The multidisciplinary management of menopausal symptoms after breast cancer: a unique model of care","volume":"17","year":"2010","journal-title":"Menopause"},{"issue":"10","key":"key\n\t\t\t\t20171006135948_B19","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/annonc\/mdn353","article-title":"Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer","volume":"19","year":"2008","journal-title":"Ann Oncol"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.maturitas.2012.07.010","article-title":"The management of menopausal symptoms in breast cancer survivors: case-based approach","volume":"73","year":"2012","journal-title":"Maturitas"},{"issue":"1","key":"key\n\t\t\t\t20171006135948_B21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/13697130500487224","article-title":"Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life","volume":"9","year":"2006","journal-title":"Climacteric"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/GME.0b013e3182976f46","article-title":"Nature and severity of menopausal symptoms and their impact on quality of life and sexual function in cancer survivors compared with women without a cancer history","volume":"21","year":"2014","journal-title":"Menopause"},{"issue":"4","key":"key\n\t\t\t\t20171006135948_B23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/01.GME.0000151655.10243.48","article-title":"Menopause symptoms and quality of life in women aged 45 to 65 years with and without breast cancer","volume":"12","year":"2005","journal-title":"Menopause"},{"issue":"2","key":"key\n\t\t\t\t20171006135948_B24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2702.2004.01030.x","article-title":"Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors","volume":"14","year":"2005","journal-title":"J Clin Nurs"},{"issue":"1","key":"key\n\t\t\t\t20171006135948_B25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0378-5122(03)00087-2","article-title":"Menopause after breast cancer: a survey on breast cancer survivors","volume":"45","year":"2003","journal-title":"Maturitas"},{"issue":"5","key":"key\n\t\t\t\t20171006135948_B26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/01.GME.0000117061.40493.AB","article-title":"Association of breast cancer and its therapy with menopause-related symptoms","volume":"11","year":"2004","journal-title":"Menopause"},{"issue":"6","key":"key\n\t\t\t\t20171006135948_B27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0885-3924(02)00395-0","article-title":"Prevalence and treatment of menopausal symptoms among breast cancer survivors","volume":"23","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"key\n\t\t\t\t20171006135948_B28","doi-asserted-by":"crossref","unstructured":"Seib C. Menopause symptom clusters and their correlates in women with and without a history of breast cancer. Menopause. 2017;24(6):624\u2013634.","DOI":"10.1097\/GME.0000000000000810"},{"issue":"1","key":"key\n\t\t\t\t20171006135948_B29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1200\/JCO.1999.17.1.120","article-title":"Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis","volume":"17","year":"1999","journal-title":"J Clin Oncol"},{"issue":"2","key":"key\n\t\t\t\t20171006135948_B30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00198-014-2945-5","article-title":"Minimal-trauma fracture in women with breast cancer surviving for at least 5\u00a0years from diagnosis","volume":"26","year":"2015","journal-title":"Osteoporos Int"},{"issue":"6","key":"key\n\t\t\t\t20171006135948_B31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clbc.2015.06.005","article-title":"Genitourinary syndrome of menopause in breast cancer survivors: are we facing new and safe hopes?","volume":"15","year":"2015","journal-title":"Clin Breast Cancer"},{"key":"key\n\t\t\t\t20171006135948_B32","unstructured":"Santen RJ , LoprinziCL, CasperRF. Menopausal hot flashes. Available at: https:\/\/www.uptodate.com\/contents\/menopausal-hot-flashes. Accessed 15 August 2017."},{"key":"key\n\t\t\t\t20171006135948_B33","first-page":"1155","article-title":"2015 position statement of The North American Menopause Society","volume-title":"Menopause.","author":"Nonhormonal management of menopause-associated vasomotor symptoms","year":"2015"},{"key":"key\n\t\t\t\t20171006135948_B34","doi-asserted-by":"crossref","unstructured":"Daley A , Stokes-LampardH, MacarthurC. Exercise for vasomotor menopausal symptoms. Cochrane Database Syst Rev. 2014;11:CD006108.","DOI":"10.1002\/14651858.CD006108.pub4"},{"issue":"7","key":"key\n\t\t\t\t20171006135948_B35","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/GME.0000000000000625","article-title":"Exercise training reduces the frequency of menopausal hot flushes by improving thermoregulatory control","volume":"23","year":"2016","journal-title":"Menopause"},{"issue":"2","key":"key\n\t\t\t\t20171006135948_B36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/AOG.0000000000000927","article-title":"Pooled analysis of six pharmacologic and nonpharmacologic interventions for vasomotor symptoms","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"9","key":"key\n\t\t\t\t20171006135948_B37","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/gme.0b013e31824f606e","article-title":"Effects of a dietary intervention and weight change on vasomotor symptoms in the Women\u2019s Health Initiative","volume":"19","year":"2012","journal-title":"Menopause"},{"issue":"5","key":"key\n\t\t\t\t20171006135948_B38","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1158\/1055-9965.EPI-10-1041","article-title":"Soy food consumption and breast cancer prognosis","volume":"20","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"key\n\t\t\t\t20171006135948_B39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/GME.0000000000000363","article-title":"A cross-sectional study of equol producer status and self-reported vasomotor symptoms","volume":"22","year":"2015","journal-title":"Menopause"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/gme.0b013e31826ce3ed","article-title":"Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial","volume":"20","year":"2013","journal-title":"Menopause"},{"issue":"2","key":"key\n\t\t\t\t20171006135948_B41","first-page":"162","article-title":"Stellate ganglion block for the treatment of hot flashes in patients with breast cancer: a literature review","volume":"15","year":"2015","journal-title":"Ochsner J"},{"issue":"15","key":"key\n\t\t\t\t20171006135948_B42","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1200\/JCO.2015.63.2893","article-title":"Acupuncture as an integrative approach for the treatment of hot flashes in women with breast cancer: a prospective multicenter randomized controlled trial (AcCliMaT)","volume":"34","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4","key":"key\n\t\t\t\t20171006135948_B43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/aim.2011.004085","article-title":"Acupuncture for hot flushes in perimenopausal and postmenopausal women: a randomised, sham-controlled trial","volume":"29","year":"2011","journal-title":"Acupunct Med"},{"issue":"1","key":"key\n\t\t\t\t20171006135948_B44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10549-016-4099-y","article-title":"Prognostic factors in early breast cancer associated with body mass index, physical functioning, physical activity, and comorbidity: data from a nationwide Danish cohort","volume":"162","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"key\n\t\t\t\t20171006135948_B45","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/gme.0b013e31826226f2","article-title":"A decade after the Women\u2019s Health Initiative: the experts do agree","volume":"19","year":"2012","journal-title":"Menopause"},{"issue":"23","key":"key\n\t\t\t\t20171006135948_B46","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.jacc.2013.03.031","article-title":"Relationship of sedentary behavior and physical activity to incident cardiovascular disease: results from the Women\u2019s Health Initiative","volume":"61","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"key\n\t\t\t\t20171006135948_B47","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/13697137.2017.1286890","article-title":"Exercise and nutritional approaches to prevent frail bones, falls and fractures: an update","volume":"20","year":"2017","journal-title":"Climacteric"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B48","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.maturitas.2014.07.004","article-title":"Obesity is associated with a poorer prognosis in women with hormone receptor positive breast cancer","volume":"79","year":"2014","journal-title":"Maturitas"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B49","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/ntr\/nts182","article-title":"Smoking status, physical health-related quality of life, and mortality in middle-aged and older women","volume":"15","year":"2013","journal-title":"Nicotine Tob Res"},{"issue":"2","key":"key\n\t\t\t\t20171006135948_B50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/JCN.0b013e31823cbef8","article-title":"Assessing and managing metabolic syndrome and cardiovascular risk in midlife women","volume":"28","year":"2013","journal-title":"J Cardiovasc Nurs"},{"issue":"10","key":"key\n\t\t\t\t20171006135948_B51","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1002\/ijc.30654","article-title":"Mediterranean diet adherence and risk of postmenopausal breast cancer: results of a cohort study and meta-analysis","volume":"140","year":"2017","journal-title":"Int J Cancer"},{"issue":"4","key":"key\n\t\t\t\t20171006135948_B52","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.maturitas.2009.12.018","article-title":"Does daily vitamin D 800 IU and calcium 1000 mg supplementation decrease the risk of falling in ambulatory women aged 65\u201371 years? A 3-year randomized population-based trial (OSTPRE-FPS)","volume":"65","year":"2010","journal-title":"Maturitas"},{"key":"key\n\t\t\t\t20171006135948_B53","doi-asserted-by":"crossref","unstructured":"Avenell A , GillespieWJ, GillespieLD, O\u2019ConnellD. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2009; (2):CD000227.","DOI":"10.1002\/14651858.CD000227.pub3"},{"issue":"2","key":"key\n\t\t\t\t20171006135948_B54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jocd.2011.03.004","article-title":"The 2011 IOM report on vitamin D and calcium requirements for north america: clinical implications for providers treating patients with low bone mineral density","volume":"14","year":"2011","journal-title":"J Clin Densitom"},{"key":"key\n\t\t\t\t20171006135948_B55","volume-title":"Dietary Reference Intakes for Calcium and Vitamin D","author":"Institute of Medicine","year":"2011"},{"issue":"1","key":"key\n\t\t\t\t20171006135948_B56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"key\n\t\t\t\t20171006135948_B57","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Endocrine Society","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B58","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jamaoncol.2016.4188","article-title":"Association of serum level of vitamin D at diagnosis with breast cancer survival: a case-cohort analysis in the pathways study","volume":"3","year":"2017","journal-title":"JAMA Oncol"},{"issue":"9","key":"key\n\t\t\t\t20171006135948_B59","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/GME.0000000000000421","article-title":"Facilitating lifestyle changes to manage menopausal symptoms in women with breast cancer: a randomized controlled pilot trial of The Pink Women\u2019s Wellness Program","volume":"22","year":"2015","journal-title":"Menopause"},{"issue":"10","key":"key\n\t\t\t\t20171006135948_B60","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/GME.0000000000000676","article-title":"Characterizing the trajectories of vasomotor symptoms across the menopausal transition","volume":"23","year":"2016","journal-title":"Menopause"},{"issue":"8","key":"key\n\t\t\t\t20171006135948_B61","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1200\/JCO.2001.19.8.2357","article-title":"Hormone replacement therapy after breast cancer: a systematic review and quantitative assessment of risk","volume":"19","year":"2001","journal-title":"J Clin Oncol"},{"issue":"4","key":"key\n\t\t\t\t20171006135948_B62","doi-asserted-by":"crossref","first-page":"R535","DOI":"10.1186\/bcr1035","article-title":"Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence","volume":"7","year":"2005","journal-title":"Breast Cancer Res"},{"issue":"9407","key":"key\n\t\t\t\t20171006135948_B63","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","article-title":"HABITS (hormonal replacement therapy after breast cancer\u2013is it safe?), a randomised comparison: trial stopped","volume":"363","author":"HABITS Steering and Data Monitoring Committees","year":"2004","journal-title":"Lancet"},{"issue":"7","key":"key\n\t\t\t\t20171006135948_B64","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn058","article-title":"Increased risk of recurrence after hormone replacement therapy in breast cancer survivors","volume":"100","author":"HABITS Study Group","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"key\n\t\t\t\t20171006135948_B65","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/dji071","article-title":"Menopausal hormone therapy after breast cancer: the Stockholm randomized trial","volume":"97","author":"Stockholm Breast Cancer Study Group","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20171006135948_B66","doi-asserted-by":"crossref","unstructured":"Kenemans P , BundredNJ, FoidartJM, KubistaE, von SchoultzB, SismondiP, Vassilopoulou-SellinR, YipCH, EgbertsJ, Mol-ArtsM, MulderR, van OsS, BeckmannMW; LIBERATE Study Group. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol. 2009;10(2):135\u2013146.","DOI":"10.1016\/S1470-2045(08)70341-3"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B67","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/AOG.0b013e31824e12ce","article-title":"ACOG Practice Bulletin No. 126: Management of gynecologic issues in women with breast cancer","volume":"119","author":"Committee on Practice Bulletins-Gynecology","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"6","key":"key\n\t\t\t\t20171006135948_B68","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1200\/JCO.2015.64.3809","article-title":"American Cancer Society\/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline","volume":"34","year":"2016","journal-title":"J Clin Oncol"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B69","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/GME.0000000000000520","article-title":"Continuous transdermal nitroglycerin therapy for menopausal hot flashes: a single-arm, dose-escalation trial","volume":"23","year":"2016","journal-title":"Menopause"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B70","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10549-016-3765-4","article-title":"Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions","volume":"156","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"key\n\t\t\t\t20171006135948_B71","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ctrv.2016.11.012","article-title":"Management of hot flashes in women with breast cancer receiving ovarian function suppression","volume":"52","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"key\n\t\t\t\t20171006135948_B72","doi-asserted-by":"crossref","unstructured":"Shams T, Firwana B, Habib F, Alshahrani A, Alnouh B, Murad MH, Ferwana M. SSRIs for hot flashes: a systematic review and meta-analysis of randomized trials. J Gen Intern Med. 2014;29(1):204\u2013213.","DOI":"10.1007\/s11606-013-2535-9"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B73","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/gme.0b013e31818c91ca","article-title":"Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis","volume":"16","year":"2009","journal-title":"Menopause"},{"issue":"17","key":"key\n\t\t\t\t20171006135948_B74","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.295.17.2057","article-title":"Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis","volume":"295","year":"2006","journal-title":"JAMA"},{"issue":"2","key":"key\n\t\t\t\t20171006135948_B75","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/PSY.0000000000000143","article-title":"Placebo improvement in pharmacologic treatment of menopausal hot flashes: time course, duration, and predictors","volume":"77","year":"2015","journal-title":"Psychosom Med"},{"key":"key\n\t\t\t\t20171006135948_B76","doi-asserted-by":"crossref","unstructured":"Sassarini J, Anderson RA. New pathways in the treatment for menopausal hot flashes. Lancet. 2017;389(10081):1775\u20131777.","DOI":"10.1016\/S0140-6736(17)30886-3"},{"issue":"4 Pt 1","key":"key\n\t\t\t\t20171006135948_B77","first-page":"655","article-title":"Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a 20-year experience","volume":"15","year":"2008","journal-title":"Menopause"},{"key":"key\n\t\t\t\t20171006135948_B78","first-page":"i5014","article-title":"Risk of mortality with concomitant use of tamoxifen and selective serotonin reuptake inhibitors: multi-database cohort study","volume":"354","year":"2016","journal-title":"BMJ"},{"issue":"2","key":"key\n\t\t\t\t20171006135948_B79","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40262-015-0315-x","article-title":"Augmentation of endoxifen exposure in tamoxifen-treated women following SSRI switch","volume":"55","year":"2016","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"key\n\t\t\t\t20171006135948_B80","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1517\/17425255.2015.1052791","article-title":"Effect of cytochrome P450 polymorphism on the action and metabolism of selective serotonin reuptake inhibitors","volume":"11","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B81","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/02841860903575273","article-title":"Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen","volume":"49","year":"2010","journal-title":"Acta Oncol"},{"key":"key\n\t\t\t\t20171006135948_B82","unstructured":"In brief: Tamoxifen and SSRI interaction. Med Lett Drugs Ther. 2009;51:45."},{"issue":"10","key":"key\n\t\t\t\t20171006135948_B83","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2016-2348","article-title":"Independent contributions of nocturnal hot flashes and sleep disturbance to depression in estrogen-deprived women","volume":"101","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"key\n\t\t\t\t20171006135948_B84","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1200\/JCO.2008.19.6253","article-title":"Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis","volume":"27","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"key\n\t\t\t\t20171006135948_B85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000226884","article-title":"High-dose medroxyprogesterone acetate versus oophorectomy as first-line therapy of advanced breast cancer in premenopausal patients","volume":"48","year":"1991","journal-title":"Oncology"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B86","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0277-5379(98)90012-8","article-title":"Adjuvant therapy for operable breast cancer with medroxyprogesterone acetate alone in postmenopausal patients or in combination with CMF in premenopausal patients","volume":"24","year":"1988","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"2","key":"key\n\t\t\t\t20171006135948_B87","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1210\/edrv-11-2-221","article-title":"Endocrine treatment of breast cancer in women","volume":"11","year":"1990","journal-title":"Endocr Rev"},{"issue":"8","key":"key\n\t\t\t\t20171006135948_B88","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/gme.0b013e318247f07a","article-title":"Oral micronized progesterone for vasomotor symptoms: a placebo-controlled randomized trial in healthy postmenopausal women","volume":"19","year":"2012","journal-title":"Menopause"},{"issue":"8","key":"key\n\t\t\t\t20171006135948_B89","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.2007.13.4338","article-title":"Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer","volume":"26","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B90","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ijc.20710","article-title":"Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort","volume":"114","year":"2005","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20171006135948_B91","doi-asserted-by":"crossref","unstructured":"Fournier A, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F. Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks? J Clin Oncol. 2009;27(31):5138\u20135143.","DOI":"10.1200\/JCO.2008.21.6432"},{"issue":"2","key":"key\n\t\t\t\t20171006135948_B92","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10549-014-2934-6","article-title":"Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort","volume":"145","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"key\n\t\t\t\t20171006135948_B93","doi-asserted-by":"crossref","first-page":"e78016","DOI":"10.1371\/journal.pone.0078016","article-title":"Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171006135948_B94","doi-asserted-by":"crossref","unstructured":"Santen R , PritchardK, BurgerH. The consensus conference on treatment of estrogen deficiency symptoms in women surviving breast cancer. Obstet Gynecol Surv. 1998;53(10 Suppl):S1\u201383.","DOI":"10.1097\/00006254-199810001-00001"},{"key":"key\n\t\t\t\t20171006135948_B95","doi-asserted-by":"crossref","unstructured":"Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017;24(7)728\u2013753.","DOI":"10.1097\/GME.0000000000000921"},{"issue":"2","key":"key\n\t\t\t\t20171006135948_B96","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/13697137.2014.947254","article-title":"Vaginal administration of estradiol: effects of dose, preparation and timing on plasma estradiol levels","volume":"18","year":"2015","journal-title":"Climacteric"},{"issue":"22","key":"key\n\t\t\t\t20171006135948_B97","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/jnci\/93.22.1714","article-title":"Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol","volume":"93","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"key\n\t\t\t\t20171006135948_B98","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10549-012-2198-y","article-title":"Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case-control study","volume":"135","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"key\n\t\t\t\t20171006135948_B99","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/jnci\/93.10.754","article-title":"Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality","volume":"93","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"key\n\t\t\t\t20171006135948_B100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/cmt.6.1.45.52","article-title":"A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer","volume":"6","year":"2003","journal-title":"Climacteric"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B101","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1200\/JOP.2011.000352","article-title":"Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptor modulator","volume":"8","year":"2012","journal-title":"J Oncol Pract"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B102","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1097\/AOG.0000000000001351","article-title":"ACOG Committee Opinion No. 659: The use of vaginal estrogen in women with a history of estrogen-dependent breast cancer","volume":"127","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Gynecologic Practice","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"9324","key":"key\n\t\t\t\t20171006135948_B103","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S0140-6736(02)09088-8","article-title":"Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial","volume":"359","author":"ATAC Trialists\u2019 Group","year":"2002","journal-title":"Lancet"},{"issue":"6","key":"key\n\t\t\t\t20171006135948_B104","doi-asserted-by":"crossref","first-page":"535.e1","DOI":"10.1016\/j.ajog.2011.06.067","article-title":"Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR)","volume":"205","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"3-4","key":"key\n\t\t\t\t20171006135948_B105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11864-010-0124-2","article-title":"Breast cancer prevention: an update of the STAR trial","volume":"11","year":"2010","journal-title":"Curr Treat Options Oncol"},{"issue":"4","key":"key\n\t\t\t\t20171006135948_B106","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/jsm.12428","article-title":"Assessment of ospemifene or lubricants on clinical signs of VVA","volume":"11","year":"2014","journal-title":"J Sex Med"},{"issue":"2","key":"key\n\t\t\t\t20171006135948_B107","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3109\/13697137.2014.954996","article-title":"Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial","volume":"18","year":"2015","journal-title":"Climacteric"},{"key":"key\n\t\t\t\t20171006135948_B108","doi-asserted-by":"crossref","unstructured":"Martel C , LabrieF, ArcherDF, KeY, GonthierR, SimardJN, LavoieL, VaillancourtM, MontesinoM, BalserJ, MoyneurE, other participating members of the Prasterone Clinical Research Group. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks. J Steroid Biochem Mol Biol. 2016;159:142\u2013153.","DOI":"10.1016\/j.jsbmb.2016.03.016"},{"issue":"7","key":"key\n\t\t\t\t20171006135948_B109","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/GME.0000000000000613","article-title":"Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial","volume":"23","year":"2016","journal-title":"Menopause"},{"issue":"4","key":"key\n\t\t\t\t20171006135948_B110","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1634\/theoncologist.2010-0435","article-title":"Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I\/II study","volume":"16","year":"2011","journal-title":"Oncologist"},{"issue":"4","key":"key\n\t\t\t\t20171006135948_B111","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.maturitas.2015.08.001","article-title":"Genitourinary syndrome of menopause and the use of laser therapy","volume":"82","year":"2015","journal-title":"Maturitas"},{"key":"key\n\t\t\t\t20171006135948_B112"},{"key":"key\n\t\t\t\t20171006135948_B113","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.maturitas.2017.01.012","article-title":"Laser therapy for the restoration of vaginal function","volume":"99","year":"2017","journal-title":"Maturitas"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B114","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/GME.0000000000000761","article-title":"Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors","volume":"24","year":"2017","journal-title":"Menopause"},{"key":"key\n\t\t\t\t20171006135948_B115","doi-asserted-by":"crossref","unstructured":"Worsley R , BellRJ, GartoullaP, RobinsonPJ, DavisSR. Moderate-severe vasomotor symptoms are associated with moderate-severe depressive symptoms. J Womens Health (Larchmt). 2017;26(7):712\u2013718.","DOI":"10.1089\/jwh.2016.6142"},{"issue":"12","key":"key\n\t\t\t\t20171006135948_B116","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.5665\/sleep.3244","article-title":"A gonadotropin-releasing hormone agonist model demonstrates that nocturnal hot flashes interrupt objective sleep","volume":"36","year":"2013","journal-title":"Sleep"},{"key":"key\n\t\t\t\t20171006135948_B117","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jsbmb.2013.06.001","article-title":"Cognition and mood in perimenopause: a systematic review and meta-analysis","volume":"142","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"key\n\t\t\t\t20171006135948_B118","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1744-9081-8-35","article-title":"An overview of the neuro-cognitive processes involved in the encoding, consolidation, and retrieval of true and false memories","volume":"8","year":"2012","journal-title":"Behav Brain Funct"},{"issue":"11","key":"key\n\t\t\t\t20171006135948_B119","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1212\/01.wnl.0000276984.19542.e6","article-title":"Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause","volume":"69","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1258\/mi.2008.008016","article-title":"Prophylactic oophorectomy in premenopausal women and long-term health","volume":"14","year":"2008","journal-title":"Menopause Int"},{"issue":"13","key":"key\n\t\t\t\t20171006135948_B121","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1111\/1471-0528.12828","article-title":"Impact of a premature menopause on cognitive function in later life","volume":"121","year":"2014","journal-title":"BJOG"},{"issue":"8","key":"key\n\t\t\t\t20171006135948_B122","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/annonc\/mdn164","article-title":"Practical guidance for the management of aromatase inhibitor-associated bone loss","volume":"19","year":"2008","journal-title":"Ann Oncol"},{"issue":"17","key":"key\n\t\t\t\t20171006135948_B123","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1016\/j.ejca.2006.07.005","article-title":"Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomised, placebo-controlled study","volume":"42","year":"2006","journal-title":"Eur J Cancer"},{"issue":"9869","key":"key\n\t\t\t\t20171006135948_B124","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial","volume":"381","author":"Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group","year":"2013","journal-title":"Lancet"},{"issue":"9354","key":"key\n\t\t\t\t20171006135948_B125","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(03)12342-2","article-title":"Overview of the main outcomes in breast-cancer prevention trials","volume":"361","year":"2003","journal-title":"Lancet"},{"issue":"8","key":"key\n\t\t\t\t20171006135948_B126","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-158-8-201304160-00005","article-title":"Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force","volume":"158","year":"2013","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171006135948_B127","doi-asserted-by":"crossref","unstructured":"Qaseem A , ForcieaMA, , McLean RM, Denberg TD; Clinical Guidelines Committee of the American College of Physicians. Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians. Ann Intern Med. 2017;166(11):818\u2013839.","DOI":"10.7326\/M15-1361"},{"issue":"11","key":"key\n\t\t\t\t20171006135948_B128","first-page":"749","article-title":"The use of adjuvant bisphophonates in the treatment of early-stage breast cancer","volume":"12","year":"2014","journal-title":"Clin Adv Hematol Oncol"},{"key":"key\n\t\t\t\t20171006135948_B129"},{"issue":"18","key":"key\n\t\t\t\t20171006135948_B130","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1200\/JCO.2016.70.7257","article-title":"Use of adjuvant bisphosphonates and other bone-modifying agents in breast cancer: a Cancer Care Ontario and American Society of Clinical Oncology clinical practice guideline","volume":"35","year":"2017","journal-title":"J Clin Oncol"},{"issue":"13","key":"key\n\t\t\t\t20171006135948_B131","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/CIR.0000000000000381","article-title":"Preventing and experiencing ischemic heart disease as a woman: state of the science: a scientific statement from the American Heart Association","volume":"133","author":"American Heart Association Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Hypertension, Council on Lifestyle and Cardiometabolic Health, and Council on Quality of Care and Outcomes Research","year":"2016","journal-title":"Circulation"},{"issue":"9","key":"key\n\t\t\t\t20171006135948_B132","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/jamacardio.2016.2132","article-title":"Oncocardiology\u2013past, present, and future: a review","volume":"1","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"1","key":"key\n\t\t\t\t20171006135948_B133","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJMsr1407164","article-title":"Atypical hyperplasia of the breast: risk assessment and management options","volume":"372","year":"2015","journal-title":"N Engl J Med"},{"issue":"9880","key":"key\n\t\t\t\t20171006135948_B134","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0140-6736(13)60140-3","article-title":"Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data","volume":"381","author":"SERM Chemoprevention of Breast Cancer Overview Group","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"key\n\t\t\t\t20171006135948_B135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40744-015-0013-z","article-title":"The tissue-selective estrogen complex: a review of current evidence","volume":"2","year":"2015","journal-title":"Rheumatol Ther"},{"issue":"2","key":"key\n\t\t\t\t20171006135948_B136","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1358\/dot.2015.51.2.2281023","article-title":"Bazedoxifene\/conjugated estrogens combination for the treatment of the vasomotor symptoms associated with menopause and for prevention of osteoporosis in postmenopausal women","volume":"51","year":"2015","journal-title":"Drugs Today (Barc)"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B137","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/13697137.2016.1146248","article-title":"Evaluation of efficacy and safety of conjugated estrogens\/bazedoxifene in a Latin American population","volume":"19","year":"2016","journal-title":"Climacteric"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B138","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/bcr3677","article-title":"Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes","volume":"16","year":"2014","journal-title":"Breast Cancer Res"},{"key":"key\n\t\t\t\t20171006135948_B139","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.steroids.2014.07.013","article-title":"From empirical to mechanism-based discovery of clinically useful selective estrogen receptor modulators (SERMs)","volume":"90","year":"2014","journal-title":"Steroids"},{"key":"key\n\t\t\t\t20171006135948_B140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.steroids.2014.06.004","article-title":"Development of conjugated estrogens\/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss","volume":"90","year":"2014","journal-title":"Steroids"},{"issue":"1","key":"key\n\t\t\t\t20171006135948_B141","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.maturitas.2013.10.009","article-title":"Bazedoxifene\/conjugated estrogens for managing the burden of estrogen deficiency symptoms","volume":"77","year":"2014","journal-title":"Maturitas"},{"issue":"1","key":"key\n\t\t\t\t20171006135948_B142","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1089\/jwh.2013.4392","article-title":"Evaluation of the efficacy and safety of bazedoxifene\/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective Estrogens, Menopause and Response to Therapy (SMART) trials","volume":"23","year":"2014","journal-title":"J Womens Health (Larchmt)"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B143","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.fertnstert.2009.03.113","article-title":"Evaluation of bazedoxifene\/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile","volume":"92","year":"2009","journal-title":"Fertil Steril"},{"issue":"2","key":"key\n\t\t\t\t20171006135948_B144","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/GME.0b013e318271f5e7","article-title":"Breast density changes in a randomized controlled trial evaluating bazedoxifene\/conjugated estrogens","volume":"20","year":"2013","journal-title":"Menopause"},{"issue":"5","key":"key\n\t\t\t\t20171006135948_B145","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/AOG.0b013e31828c5974","article-title":"Breast effects of bazedoxifene-conjugated estrogens: a randomized controlled trial","volume":"121","year":"2013","journal-title":"Obstet Gynecol"},{"key":"key\n\t\t\t\t20171006135948_B146","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jsbmb.2013.05.008","article-title":"Effects of menopausal hormonal therapy on occult breast tumors","volume":"137","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"key\n\t\t\t\t20171006135948_B147"},{"key":"key\n\t\t\t\t20171006135948_B148"},{"issue":"3","key":"key\n\t\t\t\t20171006135948_B149","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.yfrne.2013.07.003","article-title":"Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot flushes","volume":"34","year":"2013","journal-title":"Front Neuroendocrinol"},{"key":"key\n\t\t\t\t20171006135948_B150","doi-asserted-by":"crossref","unstructured":"Prague JK , RobertsRE, ComninosAN, ClarkeS, JayasenaCN, NashZ, DoyleC, PapadopoulouDA, BloomSR, MohideenP, PanayN, HunterMS, VeldhuisJD, WebberLC, HusonL, DhilloWS. Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389(10081):1809\u20131820.","DOI":"10.1016\/S0140-6736(17)30823-1"},{"key":"key\n\t\t\t\t20171006135948_B151","doi-asserted-by":"crossref","unstructured":"Fraser GL , DepypereH, TimmermanD, DondersG, SieprathP, RamaelS, CombalbertJ, HoveydaHR. Clinical evaluation of the NK3 receptor antagonist Fezolinetant (a.k.a. ESN364) for the treatment of menopausal hot flashes. Paper presented at: ENDO 2017, the Endocrine Society\u2019s Annual Meeting & Expo; 3 April 2017; Orlando, FL. Abstract OR 16\u20135.","DOI":"10.1016\/j.maturitas.2017.06.007"},{"issue":"23","key":"key\n\t\t\t\t20171006135948_B152","doi-asserted-by":"crossref","first-page":"33722","DOI":"10.18632\/oncotarget.9591","article-title":"Use of estetrol with other steroids for attenuation of neonatal hypoxic-ischemic brain injury: to combine or not to combine?","volume":"7","year":"2016","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20171006135948_B153","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.maturitas.2016.06.017","article-title":"Clinical effects of the fetal estrogen estetrol in a multiple-rising-dose study in postmenopausal women","volume":"91","year":"2016","journal-title":"Maturitas"},{"issue":"6","key":"key\n\t\t\t\t20171006135948_B154","first-page":"463","article-title":"Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives","volume":"20","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"19","key":"key\n\t\t\t\t20171006135948_B155","doi-asserted-by":"crossref","first-page":"17621","DOI":"10.18632\/oncotarget.4184","article-title":"Combined estrogenic and anti-estrogenic properties of estetrol on breast cancer may provide a safe therapeutic window for the treatment of menopausal symptoms","volume":"6","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"key\n\t\t\t\t20171006135948_B156","first-page":"85","article-title":"Estetrol is a weak estrogen antagonizing estradiol-dependent mammary gland proliferation","volume":"224","year":"2015","journal-title":"J Endocrinol"},{"key":"key\n\t\t\t\t20171006135948_B157","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.expneurol.2014.07.015","article-title":"Estetrol attenuates neonatal hypoxic-ischemic brain injury","volume":"261","year":"2014","journal-title":"Exp Neurol"},{"issue":"10","key":"key\n\t\t\t\t20171006135948_B158","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.15252\/emmm.201404112","article-title":"The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor \u03b1 modulation, uncoupling nuclear and membrane activation","volume":"6","year":"2014","journal-title":"EMBO Mol Med"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/102\/10\/3647\/20619988\/jc.2017-01138.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T16:40:54Z","timestamp":1692895254000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jcem\/article\/102\/10\/3647\/4058051\/Managing-Menopausal-Symptoms-and-Associated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,2]]},"references-count":158,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,8,2]]},"published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2017-01138","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10,1]]},"published":{"date-parts":[[2017,8,2]]}}}